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Abstract
Background and objectives
People receiving treatment for multidrug-resistant tuberculosis (MDR-TB) have high rates of
depression. Psychosocial support in general, and treatments for depression in particular,
form an important but neglected area of patient-centred care, and a key pillar in the global
End TB strategy. We assessed the feasibility and acceptability of a psychosocial support
package for people receiving treatment for MDR-TB in Nepal.
Methods
This feasibility study used a mixed quantitative and qualitative approach. We implemented
the intervention package in two National Tuberculosis Programme (NTP) MDR-TB treat-
ment centres and 8 sub-centres. We screened patients monthly for depression and anxiety
(cut-off24 and17 respectively on the Hopkins Symptom Checklist) and also for low
social support (cut-off3 on the Multidimensional Scale of Perceived Social Support).
Those who screened positive on either screening tool received the Healthy Activity Program
(HAP), which uses brief counselling based on behavioural activation theory. Other aspects
of the psychosocial package were information/education materials and group interactions
with other patients.
Results
We screened 135 patients, of whom 12 (9%) received HAP counselling, 115 (85%) received
information materials, 80 (59%) received an education session and 49 (36%) received at
least one group session. Eight group sessions were conducted in total. All aspects of the
intervention package were acceptable to patients, including the screening, information,
group work and counselling. Patients particularly valued having someone to talk to about
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their concerns and worries. We were able to successfully train individuals with no experi-
ence of psychological counselling to deliver HAP.
Conclusion
This psychosocial support package is acceptable to patients. The information materials we
developed are feasible to deliver in the current NTP. However, the structured psychological
counselling (HAP), is not feasible in the current NTP due to time constraints. This requires
additional investment of counsellors in TB clinics.
Introduction
Tuberculosis now kills more people globally than any other infectious disease [1]. Drug resis-
tance is a major barrier to tuberculosis control. The number of people with multidrug-resistant
tuberculosis (MDR-TB) is increasing, with an estimated 480,000 cases worldwide in 2014, the
great majority occurring in low- and middle-income countries [2]. Successful treatment and
management of MDR-TB is critical to controlling the epidemic. Experience suggests that
MDR-TB patients under treatment have a high prevalence of depression, although evidence is
limited [3–5]. Depression is likely to have a negative impact on patients’ livelihood and suc-
cessful treatment completion. WHO’s global End TB Strategy [6] promotes ‘integrated,
patient-centred care’ (which includes ‘patient support’ and ‘management of co-morbidities’)
as one of the three pillars of TB treatment. However, its implementation is a challenge for
National Tuberculosis Programmes (NTPs), particularly in low-income countries, where the
focus is on the biomedical aspects of MDR-TB, and much less attention is paid to addressing
the psychosocial needs of patients, including effectively treating depression [7, 8]. There are
few studies testing psychosocial interventions for MDR-TB patients, despite the acknowledged
importance of patient-centred care and psychosocial support [6, 9].
In Nepal, where in 2014/2015 there were 34,121 cases of TB, of whom 351 had drug resis-
tant TB [10], the NTP recognises the significant current gap in psychosocial support for their
MDR-TB patients [11, 12]. To address this, Nepal NTP is seeking to identify and develop con-
textually-relevant psychosocial interventions that can be delivered within routine NTP ser-
vices. In response we assessed the acceptability and feasibility of a psychosocial support
package delivered at health facilities within the existing NTP MDR-TB treatment programme,
which includes screening and behavioural activation counselling, and aims to address the psy-
chosocial needs of patients during MDR-TB treatment.
Methods
Study design
This feasibility study took a pragmatic approach, embedded within the existing health care
delivery system and policy context. In preparatory work prior to this study, using interviews,
focus groups, workshops and meetings with TB programme staff, we identified the potentially
high rates of symptoms of mental disorders experienced by these patients. We found that low
social support was a key issue for some patients, particularly women, and concluded that this
needed addressing in a psychosocial intervention. The preparatory work also identified the
lack of knowledge of MDR-TB symptoms and management amongst patients and their carers.
We developed the intervention package and adapted the HAP with wide engagement with
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various stakeholders including the NTP, relevant Non-Governmental Organisations (NGOs),
MDR-TB patients, their family members and TB health workers. This process has been
described in detail elsewhere [13].
In the present study, we piloted this intervention package within the NTP service provision
in Nepal. We evaluated the pilot to determine feasibility and acceptability of the intervention
through a convergent mixed methods approach using both quantitative and qualitative data.
The field work was undertaken by the Health Research and Social Development Forum
(HERD), a Nepalese research NGO.
Settings and participants
National MDR-TB treatment in Nepal follows an ambulatory approach which is provided
through 14 MDR-TB treatment centres (“centres”) where patients are registered and attend
monthly for follow-up, and 81 treatment sub-centres in 43 of 75 districts where patients
receive daily supervised treatment. Very few patients are initially hospitalised. The feasibility
study was implemented in two of these centres, one in Kathmandu (an NGO facility with 9
sub-centres), the other in Rupandehi (a government-owned facility with 8 sub-centres). These
two centres were purposively selected based on high case load and expressed motivation of the
health workers to deliver a psychosocial intervention. Four sub-centres were purposively
selected per centre based on their proximity to the centre and motivation of health workers to
deliver psychosocial support.
Potential participants in the pilot intervention were all those receiving treatment for
MDR-TB (i.e. both those already on treatment and those newly diagnosed, without restriction)
in the two centres and eight sub-centres between March 2015 and May 2016. All MDR-TB
patients attending these clinics and receiving treatment were invited to participate in the study
by the TB health worker when the researchers were also present. If the patient agreed in princi-
ple, they were then informed about the study using an information sheet, and informed writ-
ten consent was obtained. Criteria for exclusion were: being without capacity to consent,
unwilling to consent, aged<18 years old or being in the last 3 months of treatment. Patients
who were interviewed for the evaluation were a sub-sample of those recruited to receive the
pilot intervention.
The piloted intervention
The psychosocial package was a stepped care model. This included education materials on
MDR TB given to all patients and family members, screening for depression followed by coun-
selling for those found to be depressed. Some patients were also able to participate in a support
group if they wished. While some aspects of the intervention (described below) were offered to
all patients (education and screening), other aspects were dependent on the screening scores
(counselling) or on the patient’s willingness to participate (group support).
Information and educational materials. Education materials were used to give informa-
tion on various aspects of MDR-TB and its treatment to all patients and family members (S1
Appendix). The materials included a flipbook (an A4 spiral bound book with pictures on the
patient-facing sheet and explanatory text for the health worker on the back), and two informa-
tion leaflets, one for patients and one for family members. While both the leaflets had informa-
tion on MDR-TB, the family member leaflet had additional information on their supportive
roles. These materials were designed to be used by the health workers in their routine consulta-
tions with patients.
Screening process. Screening for depression and anxiety was carried out using the 25
item Johns Hopkins Symptom Checklist (“HSCL”) [14], and screening for low social support
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using the Multidimensional Scale of Perceived Social Support (MSPSS) [15]. The screening
was planned to take place during patients’ monthly follow-ups at the centre and to be con-
ducted by the health workers. Patients who screened positive on at least one tool (anxiety17
or depression24 on HSCL [16]; or MSPSS3 [15]) were referred for counselling. Patients
who screened negative across both tools were rescreened a month later. HSCL was selected as
it has previously been translated and culturally adapted for use in Nepal for identification of
depression and anxiety among internally displaced people, has been shown to have moderate
validity [16], and was recommended by TPO Nepal, a Nepalese mental health NGO. There
was no validated tool to capture the perceived need for social support in the needs assessment
phase of the study [13]; the study team judged MSPSS was the most appropriate tool for the
context. MSPSS was translated from English to Nepali by the research team and verified by
back translation.
Brief counselling. Counselling was provided to those found to be depressed using the
Healthy Activity Program (HAP) approach. HAP is individual counselling based on beha-
vioural activation (BA) psychological therapy, developed in India for treating depression
within primary care using lay counsellors [17]. The core principle of BA is the use of activity
scheduling (planned timetables) to address inactivity and problems that the person avoids.
The recipient of BA identifies activities to undertake that they are likely to find enjoyable in
line with their goals and values. Behavioural activation is equivalent in effectiveness to cogni-
tive behavioural therapy for depression, but significantly cheaper [18]. HAP was selected as it
is an intervention with promising evidence from neighbouring India [19] and was already
being tested in a few districts of Nepal in primary health care settings. We worked with the
local mental health NGO who were testing HAP [20], to adapt HAP for MDR-TB-related con-
text and issues: the principles and process remained unchanged with the exception of remov-
ing detailed recording of the counselling sessions to reduce the already heavy burden of
documentation within the study. The HAP counsellor used this BA approach, as well as the
activation (or re-activation) of social networks and a positive problem-solving approach (all
aspects of the original HAP intervention from India), to help the patient identify the links
between what they did and how they feel, and then used this information to plan specific activ-
ities to begin to improve their mood. Monitoring the progress of treating the patient’s depres-
sion through HAP was done using PHQ-9 [21], which has been validated in primary care
populations in Nepal [22]. It was administered before the first session and thereafter before
every HAP session. If the first PHQ-9 screen score was below 10, patients did not receive HAP
but were returned to monthly screening. Patients whose first PHQ-9 score was over 19 (indi-
cating severe depression) or who expressed suicidal intent were referred to specialist psychiat-
ric or medical services (as available at each study site). For patients who started HAP, sessions
were continued until the PHQ-9 score reduced to less than 10, indicating restoration of the
patient’s mental wellbeing or for up to 8 sessions (lasting for 30 to 60 minutes each). If the
PHQ score was still 10 or above after 8 sessions then referral to psychiatric services was made.
HAP counsellors are typically lay people with at least high school education who receive
specific training in delivering HAP from experienced counsellors. The initial plan was for the
TB health workers to conduct the counselling, however, early discussions with participating
centres made it clear that this would not be feasible. In light of this two additional staff from
HERD were trained to deliver the counselling in the centres. Both counsellors had public
health backgrounds: one had extensive experience of TB programme work, and the other had
a physiotherapy bachelors degree, but neither had previous formal counselling experience.
Although most patients in Kathmandu speak and understand Nepali, in Rupandehi a signifi-
cant minority do not, so the counsellor there was chosen for a familiarity with several local lan-
guages. Different tools were used for monthly screening (HSCL and MSPSS) and HAP
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monitoring (PHQ-9) as we wanted to identify anxiety as well as depression in the monthly
screening, which the HSCL tool does. The PHQ-9 was the recommended and evidenced tool
to monitor HAP and so was used for this purpose.
Group support. Interactions among patients in groups were used to increase patients’
understanding of MDR-TB and its treatment, reduce their negative emotions and improve
their social support. Attendance at a group session was offered to all patients. A group of 8–15
people (mixed age and gender) with MDR-TB met regularly for up to an hour at the health
facility, where they shared experiences and supported each other to face and overcome the
challenges they were living with as a result of MDR-TB and its treatment. We planned a struc-
tured approach where the same group of patients would attend four consecutive sessions, cov-
ering important issues which would build trust and rapport between group members,
increasing their ability to support one another. The group was facilitated by a counsellor, and
often included a cured patient who shared experiences to provide motivation and instil hope
in the group members. Group support has been shown to be beneficial in Peru where it has
been a mainstay of MDR-TB care [23]. This aspect of the intervention package was developed
in the second half of the study period after reviewing progress.
Training. Six days training was provided to MDR-TB health workers and counsellors by
the mental health NGO, TPO. This consisted of a recap of MDR-TB modular training pro-
vided by the NTP, orientation to the information materials we developed for the study, basic
skills of counselling including rapport building, using screening tools and delivering HAP. A
further two days training was provided to the counsellors by the study team covering recording
and process documentation of the research study.
Evaluation of the intervention
We used both quantitative and qualitative data to assess feasibility of the intervention. These
were combined using a convergent mixed-methods approach [24]. The objective of this evalu-
ation was to determine the feasibility and acceptability of the intervention in the routine
MDR-TB treatment service of the NTP.
Quantitative data. The quantitative data was collected from four sources between March
2015 and May 2016. The first was routine TB registers at the TB clinic. Data collected included:
date diagnosed with MDR-TB, date started treatment, new or relapse case and sputum culture
status. The second source was a data collection tool designed for this study, which collected
self-reported socio-demographic data from the patient such as age, sex, education and occupa-
tion. The third source was the screening tools (HSCL, MSPSS and PHQ-9) which produced
scores at each screening point for each patient. The fourth source was a researcher diary which
collected process data from the counsellors and was used to identify such things as the percent-
age of patients who received different parts of the package and the time taken to deliver inter-
ventions. This measured fidelity to the planned intervention.
All quantitative data were manually input into a spreadsheet. Any outliers or gaps were
checked with the counsellor and/or clinic registers. The whole dataset was then manually
checked for consistency and completeness. Subsequently SPSS (version 20) was used to analyse
the data and calculate descriptive statistics. As this was a feasibility study, no formal sample
size estimation was carried out.
Qualitative data. A semi-structured format of the researcher diary with space for free-for-
mat text was provided to enable the counsellors to reflect on the implementation of the pilot
intervention (S2 Appendix). The diary was completed by the counsellors initially on a daily
basis, and later reduced to weekly, bi-weekly and then monthly reporting. The counsellors also
wrote reflective notes to summarise their observations of delivering the intervention. After
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each HAP counselling session, the counsellors also made some brief notes on the content of
the session to assess fidelity to the model.
Interviews were conducted with the counsellors, some of the MDR-TB patients who
received HAP and TB health workers. Interview guides were developed for each group based
on the information within the daily diary, informal conversation with the counsellors, aspects
of the intervention that we wanted to assess and areas where there were information gaps (S3
Appendix). Two rounds of interviews were conducted with the counsellors, one on month 9 of
the intervention and the other at the end of the intervention, to more thoroughly understand
the implementation and the context at the MDR-TB centres. The number of interviews was
fixed with counsellors and TB health workers as there was a limited number of these staff (all
were interviewed). Interviews with patients were continued until the interviewers considered
data saturation had been reached.
Qualitative data from interviews were translated from Nepali into English by experienced
translators and transcribed to English as literally as possible. These transcripts, daily diaries,
reflective notes and HAP session comments were uploaded into NVivo (version 11). In accor-
dance with the framework approach in qualitative analysis [25], two researchers thematically
coded two interview transcripts and from this an agreed thematic framework was developed.
This was then checked independently by a third researcher. The framework was then used to
code all subsequent transcripts and diaries. Any deviant data were identified; further themes
were considered and agreed between the two researchers, and the framework adjusted
accordingly.
Ethics. Ethics approval for the study was obtained from Nepal Health Research Council
(Approval number: 130/2012) and University of Leeds Medical Research Ethics Committee
(Approval number: HSLTM/11/026). Written informed consent was obtained from all
research participants. Illiterate patients were informed verbally and confirmed consent using
thumb prints. No incentives were provided to participants.
Results
During the implementation period (March 2015-May 2016) 197 patients were registered in the
two MDR-TB treatment centres. Of these, 135 patients were eligible, consented and were
enrolled in the study. Reasons for patients not being enrolled included: non-attendance at the
clinic, disruption to the project from the large earthquake in April 2015 and meeting the exclu-
sion criteria for recruitment. Details of enrolled patients’ characteristics are shown in Table 1.
Males outnumbered females (76% v 24%). The sample was generally quite young. A majority
of the sample was married (67%). A majority lived with a spouse or family members (30% stay-
ing alone, 68% staying with family/spouse). More participants were recruited in Rupandehi
than Kathmandu (61% v 39%). Only three participants (2%) reported not working before
MDR-TB, compared with 94 (70%) after being diagnosed.
The data for qualitative analysis was obtained from 11 interviews (5 patients, 2 MDR-TB
health workers and two counsellors interviewed twice), 93 reflective diary entries and three
field visit reports.
During the study period the 135 patients were receiving treatment for a cumulative total of
943 months. We obtained monthly screening data for 693 of these months (73%). Missing data
for monthly screening was due to patient non-attendance at the centres. Of the 135 patients
screened with HSCL and MSPSS, 3 screened positive for low social support and 30 screened
positive for depression and/or anxiety indicating the need for further counselling (see Fig 1).
All three patients who had screened positive for low social support (MSPSS score) also
screened positive for depression (HSCL). Therefore, a total of 30 patients were eligible for
Feasibility of psychosocial support for MDR-TB patients in Nepal
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HAP counselling after screening. One patient who screened positive on HSCL was (mistak-
enly) not referred for HAP counselling: the remaining 29 were referred for counselling. Of the
29, six patients had a very high baseline score on PHQ-9 (>19) (administered as part of the
HAP process) indicating severe depression. Instead of receiving HAP counselling they were
referred to a MDR-TB health worker/physician/psychiatrist depending on availability at the
health centre, due to their psychiatric needs. Of the 29 patients, 12 had a moderate PHQ-9
score (10–19) and were counselled using HAP. There were 11 patients who had a low PHQ-9
score (<10) and were not eligible for HAP counselling, and were therefore returned to routine
monthly screening.
Of the 135 patients, 115 (85%) received a patient information leaflet, and 36 patients’ (27%)
family member(s) received a family information leaflet. 80 (59%) patients received one flip-
book session, which the counsellors reported took on average 15–20 minutes. Some of these
sessions at Rupandehi were delivered by student nurses on placement at the clinic after train-
ing from the counsellor and TB health worker.
A total of eight group support sessions were delivered during the study with a total of 49
(36%) patients receiving at least one group session. Three groups (mean size 5 patients) were
delivered in Kathmandu involving a total of 14 patients and 5 groups (mean size 7 patients) in
Rupandehi involving 35 patients.
Feasibility and acceptability of the psychosocial package
The screening process. Within the first month of implementation the MDR-TB health
workers stated that they were unable to perform the role of initial screening of all MDR-TB
patients due to the heavy patient flow and time constraints. This was in spite of the fact that
the intervention was developed with their full engagement and they had agreed this role. With
limited opening hours between 10am and 2pm and MDR-TB patients from the sub-centres
presenting on just two days per month, health workers could not manage the screening of the
patients. Therefore, the counsellors themselves undertook the screening process which they
had enough time to do. For the last month of the study the MDR-TB health workers were
asked to use a locally developed ultra-brief screening tool[22] using two questions similar to
PHQ-2, but using Nepali idioms of psychological distress. They did this and reported having
Table 1. Patient characteristics.
Characteristics N = 135
Age 30 (23–43)
Sex Male 102 (76%)
Female 33 (24%)
Occupation Not working before MDR diagnosis 3 (2%)
Not working after MDR Diagnosis 94 (70%)
Family situation Staying alone 41 (30%)
With family/spouse 92 (68%)
Others (hostel) 2 (2%)
Marital status Not married 44 (33%)
Married 88 (65%)
Widowed 3 (2%)
Treatment centre Kathmandu 52 (39%)
Rupandehi 83 (61%)
Data are n (%) or median (interquartile range).
https://doi.org/10.1371/journal.pone.0201163.t001
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enough time to undertake this for every MDR-TB patient, indicating the use of two questions
as an initial screen is feasible without additional resources in the current TB service.
“If there is a separate person [for screening], then it is good to go through HOPKINS and
MSPSS, but if he [MDR-TB health worker] has to implement in the regular system . . .
then the two questions will be better. It is short and doesn’t take too much time.” (Counsel-
lor 2)
Fig 1. Flow diagram of the screening process in this study.  These 3 patients with MSPSS<3 also screened positive for depression or anxiety on the Hopkins
tool.  1 patient with a high Hopkins score was (mistakenly) not referred to the counsellor and so not counted here.
https://doi.org/10.1371/journal.pone.0201163.g001
Feasibility of psychosocial support for MDR-TB patients in Nepal
PLOS ONE | https://doi.org/10.1371/journal.pone.0201163 July 26, 2018 8 / 15
One of the benefits of this revised delivery method using the counsellors was there was min-
imal waiting time for the patient to be screened. The counsellors managed to perform over
70% of the planned monthly screening sessions, providing plenty of opportunity to identify
patients with depression, indicating the feasibility of this approach. Counsellors were also posi-
tive about using HSCL and MSPSS (compared to just PHQ-9) for screening because it pro-
vided richer information for the HAP counselling session as they knew more about the
patient’s state of mind and social support. They reported it took them 10–15 minutes to com-
plete the screening process for each patient.
Counsellors reported that, due to cultural factors, one question in the HSCL tool (relating
to sexual interest) was uncomfortable to ask and for patients to answer. Other questions in the
tools were acceptable. Counsellors also reported that patients referred for HAP complained
about the repetition of the questions in the two screening tools (HSCL and PHQ-9).
Information and educational materials. The convenience of giving the leaflet to patients
led to the MDR-TB health workers providing one to a majority of patients. However, although
the MDR-TB workers initially used the flipbook in their contact with new patients, this practice
soon stopped. Although it only took 5–10 minutes to go through, this seemed to become a bar-
rier to them using the flipbook. They stated that they gave the same messages but more briefly.
“It [the flipbook] is very difficult for us [to use for every patient]. It is practical in places that
have a small number of patients. On the other hand, this facility has a large volume of
patients here.” MDR-TB Health worker 2
“The things I used to give are also from the flip book. I finish up saying the things in two
lines.”MDR-TB Health worker 2
All the information materials were in Nepali and for a majority of patents these could be
understood; however, for a minority of patients at Rupandehi who did not speak Nepali, this
presented a barrier. This was overcome by the counsellor translating the content into a local
language.
Most of the patients found the information materials (particularly the pictures) helpful to
understand MDR-TB and its management better, which reduced their mental stress (see quote
from Counsellor 2 below). Some also stated that the intervention should be available in all
MDR-TB centres.
“In the beginning, I was interested to know what it [the leaflet] was. I felt like reading it and I
read it too. When I found out that it was about my own [condition], my ‘interest’ grew even
more.” Rupandehi Pt 3, Female
“If we screen some patients and if we counsel them they said that their results came good.
They also said that, ‘Sir, we didn’t know about TB and we didn’t know with whom to share.
Because of this, we were depressed but after you came, we could share with you everything,
we knew everything regarding its transmission. And after sharing these things I felt
relaxed. . .’” Counsellor 2
The HAP counselling. It took 30–45 minutes to deliver each HAP session. Due to the
availability of the counsellor as an extra member of staff, the time patients spent waiting to
receive HAP counselling was minimal.
Twelve of the 135 (9%) patients received the HAP counselling. The median number of
HAP sessions delivered per patient was 2.5 (range 1–4). Only one patient brought a family
member to the HAP counselling (for two sessions). With the counsellors also undertaking the
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screening, there was generally no waiting time between screening and delivery of the HAP ses-
sions as they occurred consecutively. There was a single instance where two patients were
identified to receive HAP on the same day resulting in a longer waiting time for one of them.
However, a key limitation of delivering the HAP sessions was the lack of an appropriate, pri-
vate space in which to conduct the counselling at the centre (as was the case with screening),
which often created distractions for the patients and counsellors during counselling. The coun-
sellors had to improvise, and either used rooms that were shared with other services or an out-
side space that was as private as possible.
A review of the counsellors’ reflections indicated the focus of the HAP sessions was on
patient activities in line with the behavioural activation approach of HAP. Typical examples of
activation included patients doing breathing exercises, intentionally talking with neighbours,
starting to undertake manageable household chores, ensuring a good sleep routine and starting
to work part-time in the family business. As the counsellors took a purely oral approach to
activity planning without the use of paperwork, the counsellors reported that the patients with
low literacy were able to engage in the counselling.
There was high attendance for HAP sessions. All patients appreciated the availability of
someone with sufficient time in the centres to be able to share their problems and sorrows.
This was particularly important for those who, due to the stigma of TB, were unable to talk
openly about their condition with family and friends. In addition, all the patients interviewed
also stated that they were willing to see our counsellors and follow the agreed activities of the
HAP session.
“Before this, other people have come asking, but I never showed them my worries. And
when counsellor asked us very nicely, giving us enough time . . . I shared all my problems
with him . . . after talking with him I have improved a lot. I have felt very good after I met
the counsellor . . . and I used to follow every little thing said by him.” Kathmandu Patient 2,
Male
“What happens is we don’t share with other friends from outside about our disease. But he
asks us about how our family is and what is going on. At least there is a person in the hospi-
tal who asks us about our family . . . and that’s a big thing for us” Kathmandu Patient 3,
Male
Most of the patients identified that the behavioural activation approach using changes to
daily activities was particularly beneficial.
“Before meeting the Counsellor, I used to think a lot . . . I used to spend time gazing a lot
and continue walking unknowingly. Then the counsellor told me not to overthink and not
to take “tension” . . . and used to teach me to do these things and told me if you will do
these things then this [improvement] will happen. From then I didn’t take any kind of ten-
sion . . . after talking with him I have improved a lot” Kathmandu Pt 2, Male
“After the counselling, I tried to change myself. While I was in depression, I used to walk
around thinking, ‘I do not care whatever happens’. Because of the counselling, I got the
chance to change myself.” Rupandehi Pt 3, Female
“In my experience, one thing is that, they [patients] came out searching for him [counsel-
lor] and no more psychological problems came to me . . . the problem has been reduced
compared to last year. Not only the suicidal thoughts but also suicidal attempts had been
done here in mine [my facility]” MDR-TB HW 1
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Group support. It was not possible to retain the same members for subsequent group ses-
sions as planned because patients attended the clinics on different days of the month and
times of day. Therefore topic-based group sessions proved challenging. Instead, the counsel-
lors facilitated participants to identify the challenges they were willing to discuss in a group set-
ting on a session-by-session basis. Groups were limited to 30 minutes, based on the willingness
of patients to stay that long. As the group could only start once all the invited patients had seen
the MDR-TB health workers, the session start was often delayed, resulting in patients request-
ing shorter group sessions. Overall, patients were positive about group counselling; however,
some thought it may not suit everyone as some people would not like to express differences in
opinions and some might worry more after hearing others’ problems. In addition, many
patients expressed how beneficial it was to hear the experiences of a cured patient in the group.
“Seeing the people who have completed their course of medication will motivate the people
who are continuing their medicines. On seeing such people, they will realize that they too
can survive if they take medicines. They get motivated and they go on completing their
course” Rupandehi Patient 3, Female
“In the beginning, I used to go there, bring medicines and take them. There was no one like
that [with MDR-TB] in the village, so I used to stress out thinking that I was the only one
with that disease. When I saw all the other people here [the treatment centre], I realized
that there were others like me who were suffering from it. I got courage thinking that others
have also gone through it and they have survived.” Rupandehi Pt 5, Male
Other challenges and benefits. According to the intervention protocol, patients whose
scores indicated anxiety or severe depression were supposed to be referred to a psychiatrist.
No psychiatrists were available within the study health facilities so cases were notified to the
MDR-TB health worker, who then followed up with a physician or psychiatrist at another
facility.
The MDR-TB health workers expressed their views that the intervention was useful and a
valuable part of the service that they were offering. While they had limited time to deliver the
intervention they did provide support to facilitate the intervention process by arranging space
for counselling and encouraging patients to engage in the components of the intervention.
“The things that we have been implementing with our patients [the intervention package]
have been really good for the patients and we have had no defaulters at all. They now come
to inform us immediately whenever they have a problem. They used to hesitate to come
and talk to us before. We feel that these things [the intervention] have made the situation
far better than before.” MDR-TB Health worker 1
Preliminary HAP outcomes. Our sample size was not powered to report effectiveness of
HAP. That said, the 9 patients who completed HAP had a mean reduction in scores on both
depression tools (7.9 points on HSCL-Depression and 2.7 points on PHQ-9). This is an
encouraging signal of the possible impact of HAP on depressive symptoms in this setting, but
no firm conclusions on effectiveness can be made. Minimal change occurred for the
HSCL-Anxiety scores after HAP, compared with before HAP.
Discussion
As far as we are aware this is the first published study to implement a BA counselling approach
in the treatment of MDR-TB in a resource-constrained setting. This psychological intervention
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within a psychosocial support package shows promise as an intervention for people being
treated for MDR-TB, particularly for those with depression. We have shown that the HAP
counselling and the package as a whole is acceptable to patients. We have also demonstrated
that HAP counselling is not feasible in the current NTP due to the time taken to deliver the
counselling sessions. However, with additional resources of counsellors provided for TB clin-
ics, who are aware of local languages and have a private space to use, then HAP counselling
could be feasibly delivered as part of a package of psychosocial interventions. We have shown
that this counsellor does not need to be someone with professional qualifications. The use of
information materials and an ultra-brief screening tool for depression (2-item) is feasible to
deliver in the current NTP. With additional dedicated human resources, screening, group sup-
port and HAP counselling can feasibly be delivered in centres by counsellors or health workers
following appropriate training. The information materials developed during the study are the
first resources focusing on MDR-TB in Nepal and are now available to be scaled up across the
MDR-TB services.
Strengths of the study include the intervention being built on the findings of previous stud-
ies; an embedded approach within the existing TB service; design and development in collabo-
ration with the NTP; an intervention with existing evidence and an established theoretical
base; and contextualization to Nepal and tailoring for implementation in existing MDR-TB
services. A key challenge was disruption in the delivery of the intervention for 3 months due to
the large earthquake in April 2016 and other political unrest across the country which caused
disruption in monthly screening. Limitations of the study include the weak validation of the
HSCL screening tool and lack of validation of the MSPSS screening tool within the context of
Nepal and among this patient group; a limited number of group support sessions and evalua-
tion interviews undertaken; and untested inter-rater reliability between the two counsellors
performing screening at each centre. Finally, we only evaluated fidelity to the intervention
using counsellor diaries which has limited validity.
Our findings suggest we implemented an overly complicated screening process. We pro-
vided HAP to only a small proportion of patients (12/135). Use of a single screening tool
might have increased the number of patients identified for HAP, because using a two-stage
screening process (HSCL/MSPSS and then PHQ-9) prior to undertaking HAP led to conflict-
ing indications from screening tools and a lack of clarity about which patients were eligible for
counselling. Because of this some patients who may have benefitted from counselling did not
receive it. We therefore recommend a single screening process using PHQ-9, because PHQ-9
has been well-validated in Nepal[22] as opposed to the weaker validation for HSCL there; and
PHQ-9 screens for depression rather than anxiety, which aligns with HAP counselling which
is designed as an intervention for depression and not anxiety. That said, the TB health workers
did find the ultra-brief screening tool (Nepali version of PHQ-2) feasible in the current system.
This could be considered as part of a screening process: the health workers screen using the
PHQ-2 then refer screen positive patients to dedicated counsellors who uses the PHQ-9 to
determine if a patient is eligible to receive a counselling intervention.
There are very few published studies reporting the feasibility of psychosocial interventions
in MDR-TB patients so only limited comparisons can be made between our study and other
evidence. Our finding that HAP is acceptable in MDR-TB patients in Nepal is in line with the
findings of the previous HAP study conducted for patients with probable depression in pri-
mary care settings in India[16]. The requirement that patients attend the MDR-TB clinic regu-
larly for MDR-TB treatment monitoring aligns with the HAP mode of delivery within health
facilities. Unlike in the Indian RCT[17], we did not attempt to evaluate the effectiveness of
HAP; patients in our study who received HAP did have improved PHQ-9 scores afterwards,
but small numbers limit the conclusions that can be drawn. A study reporting on group
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counselling in Peru[23] found similar challenges to our study in recruiting and retaining
patients in groups. Other similar findings include the fact that patients found it comforting to
hear that other patients were experiencing similar problems and the beneficial use of cured
patients in groups.
Our findings suggest that certain elements of the intervention package (information materi-
als) may be beneficial for the psychosocial wellbeing of all the patients with MDR-TB and is
feasible to be delivered by health workers in existing MDR-TB services in Nepal without addi-
tional resources. The other aspects of the intervention package (screening, group support and
counselling) have some resource implications for Nepal’s NTP. This may be considered by the
NTP given that the provision of psychosocial counselling and training of health workers in
MDR-TB centres has been incorporated in the forthcoming strategy[10].
Provision of a dedicated counsellor in the MDR-TB centre, familiarity of the counsellor
with the local language, private space to deliver counselling, motivation and support of the
MDR-TB health workers for them to facilitate the intervention implementation and the need
to have a single screening tool were some of the major factors that influenced implementation
of the intervention package. Therefore, these factors must be taken into consideration before
implementing at scale. Furthermore, although we excluded patients with severe depression
(PHQ-9 score >19) from being eligible for HAP, the trial in India[17] did not make this dis-
tinction and found HAP appropriate for these patients. Therefore, it is likely HAP can be pro-
vided to all MDR-TB patients with PHQ-9 scores over 10. There may be scope within the NTP
to train MDR-TB staff to manage suicide risk and deliver pharmacological treatments for
depression but assessment of this possibility was outside the scope of our study.
Our findings lay a strong foundation for future research to test the effectiveness and cost-
effectiveness of a behavioural activation counselling approach in the management of MDR-TB
in Nepal, for instance through a randomised controlled trial. Aspects of the psychosocial pack-
age require further development such as the use of ultra-brief screening tools (e.g. PHQ-2) and
the content of group support, including the use of cured patients. However, this psychosocial
support package including screening and counselling shows promise as an intervention for
patients receiving treatment for MDR-TB who have co-morbid depression.
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